India has approved its first and the world’s third mRNA vaccine with Gennova Biopharmaceuticals Ltd’s Gemcovac-19, potentially setting up competition to leaders Pfizer Inc./BioNTech SE and Moderna, Inc. and opening the doors to development of other drugs locally using the coveted technology.
Emcure Pharmaceuticals Pvt Ltd. subsidiary Gennova’s COVID-19 vaccine, which has been in the making since 2020 via a collaboration...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

